chr8-22692822-G-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_004430.3(EGR3):āc.123C>Gā(p.Asp41Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000868 in 1,613,334 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_004430.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EGR3 | NM_004430.3 | c.123C>G | p.Asp41Glu | missense_variant | 1/2 | ENST00000317216.3 | NP_004421.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EGR3 | ENST00000317216.3 | c.123C>G | p.Asp41Glu | missense_variant | 1/2 | 1 | NM_004430.3 | ENSP00000318057.2 | ||
EGR3 | ENST00000519492.1 | c.123C>G | p.Asp41Glu | missense_variant | 1/3 | 5 | ENSP00000429370.1 | |||
ENSG00000253125 | ENST00000523627.1 | n.164+2509G>C | intron_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000264 AC: 4AN: 151560Hom.: 0 Cov.: 29
GnomAD3 exomes AF: 0.0000279 AC: 7AN: 251270Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135848
GnomAD4 exome AF: 0.00000684 AC: 10AN: 1461774Hom.: 0 Cov.: 33 AF XY: 0.00000688 AC XY: 5AN XY: 727184
GnomAD4 genome AF: 0.0000264 AC: 4AN: 151560Hom.: 0 Cov.: 29 AF XY: 0.0000270 AC XY: 2AN XY: 73992
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 30, 2023 | The c.123C>G (p.D41E) alteration is located in exon 1 (coding exon 1) of the EGR3 gene. This alteration results from a C to G substitution at nucleotide position 123, causing the aspartic acid (D) at amino acid position 41 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at